Liu, J.; Rajasekaran, N.; Hossain, A.; Zhang, C.; Guo, S.; Kang, B.; Jung, H.; Kim, H.; Wang, G.
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals 2021, 14, 719.
https://doi.org/10.3390/ph14080719
AMA Style
Liu J, Rajasekaran N, Hossain A, Zhang C, Guo S, Kang B, Jung H, Kim H, Wang G.
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals. 2021; 14(8):719.
https://doi.org/10.3390/ph14080719
Chicago/Turabian Style
Liu, Jiawang, Nirmal Rajasekaran, Ahamed Hossain, Changde Zhang, Shanchun Guo, Borui Kang, Hunsoon Jung, Hongjoong Kim, and Guangdi Wang.
2021. "Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies" Pharmaceuticals 14, no. 8: 719.
https://doi.org/10.3390/ph14080719
APA Style
Liu, J., Rajasekaran, N., Hossain, A., Zhang, C., Guo, S., Kang, B., Jung, H., Kim, H., & Wang, G.
(2021). Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals, 14(8), 719.
https://doi.org/10.3390/ph14080719